rapt logo
  • About
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Clinical and Scientific Advisors
    • Contact
  • Science
    • Immune Continuum
    • CCR4 in Inflammation
    • CCR4 in Cancer
    • Publications
  • Pipeline
    • Snapshot
    • Tivumecirnon (FLX475)
    • Discovery Programs
  • Investors
    • Corporate Profile
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Email Alerts
    • Investor Contact
    • Investor FAQs
  • Careers
    • Culture
    • Benefits
    • Open Positions
Contact Us
+1.650.489.9000
inquiries@rapt.com
  • Linked In account
  • Youtube account
rapt-logo.png
  • Home
  • About
  • Science
  • Pipeline
  • Careers
  • Terms Of Use
  • Privacy Policy
  • Linked In account
  • Youtube account

© 2024 RAPT Therapeutics, Inc.
All rights reserved.

You are leaving RAPT.com to go to the eczema clinical trial study site.
YES